Cystathionine γ‐Lyase‐Dependent S‐Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Jiani Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Cystathionine gamma-Lyase, Smad3 Protein, Hydrogen Sulfide. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for Central Universities of the Central South University, Hunan Provincial Innovation Foundation for Postgraduate.
Abstract (Originalsprache)
Objective
The cystathionine γ‐lyase (CSE)/hydrogen sulfide (H 2 S) axis has emerged as a key regulator in tissue fibrogenesis. This study aimed to explore the role of the CSE/H 2 S axis in systemic sclerosis (SSc) and to investigate its underlying mechanisms to identify promising therapeutic targets.
Methods
CSE/H 2 S levels were assessed in serum samples from 25 patients with SSc and 28 healthy controls. Human dermal fibroblasts from patients with SSc and healthy controls were used for functional studies, including propargylglycine (CSE inhibitor) treatment, Gyy4137, a slow‐releasing hydrogen sulfide donor, CSE silencing, and CSE overexpression, combined with liquid chromatography–tandem mass spectrometry (LC‐MS/MS)–based S‐sulfhydration proteomics. Molecular dynamics simulations were performed to study the effects of S‐sulfhydration on protein structure, and an Smad3 C121S (cysteine [Cys] 121 mutated to Ser) mutant was generated to verify the function targets of S‐sulfhydration. In vivo, bleomycin‐induced mouse models of skin and lung fibrosis were constructed to evaluate the effects of CSE overexpression.
Results
In human samples, CSE/H 2 S levels were reduced in SSc. CSE inhibition promoted extracellular matrix deposition. S‐sulfhydration proteomics showed that S‐sulfhydration levels were globally reduced in SSc compared to controls. CSE overexpression increased S‐sulfhydration on Smad3, suppressed transforming growth factor β 1 (TGFβ1)/Smad3 signaling, mitigating skin fibrosis. Notably, Cys121 on Smad3, identified as a pivotal target for S‐sulfhydration by proteomics, was shown to fine‐tune its MH1 domain, with its mutation impairing the antifibrotic effects. In mice, CSE overexpression attenuated bleomycin‐induced skin and lung fibrosis.
Conclusion
Smad3 S‐sulfhydration mediates the antifibrotic effect of CSE in SSc, highlighting it as a critical mechanism and promising therapeutic target. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, China.
- Hunan Key Laboratory of Medical Epigenetics, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, China.
- Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Medical Genetics, The Second Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Rong Xiao
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for Central Universities of the Central South University
- Hunan Provincial Innovation Foundation for Postgraduate
- Science and Technology Program of Hunan Province
Zitieren
APA
Liu, J., Xiao, Y., Liu, L., Xiao, X., Pi, Z., Song, Z., Yang, Q., Zeng, Z., Zhu, R., Shi, Y., & Xiao, R. (2026). Cystathionine γ‐Lyase‐Dependent S‐Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis. Arthritis & Rheumatology. https://doi.org/10.1002/art.70085
Vancouver
Liu J, Xiao Y, Liu L, Xiao X, Pi Z, Song Z, et al. Cystathionine γ‐Lyase‐Dependent S‐Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis. Arthritis & Rheumatology. 2026. doi:10.1002/art.70085
BibTeX
@article{Liu2026,
author = {Liu, Jiani and Xiao, Yangfan and Liu, Licong and Xiao, Xuan and Pi, Zixin and Song, Zehong and Yang, Qianyu and Zeng, Zhuotong and Zhu, Ruixuan and Shi, Yaqian and Xiao, Rong},
title = {Cystathionine γ‐Lyase‐Dependent S‐Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70085}
}
EUVIMED